Mylan Reaches $465M Settlement of EpiPen Misclassification Charges

The settlement nearly totals the amount Medicaid and Medicare spent on the allergy treatment in 2015. Read More

Niraparib Dramatically Increases Survival Time in BRCA-Mutated Ovarian Cancer

Niraparib also significantly improved PFS in patients with non-germline BRCA mutations. Read More
The Solutions Center